Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.46 |
| ▸ | TRPM8 | Q7Z2W7 | 5/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.44 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.34 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28108983 | 1.00 | EPHX1 (0.46) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL25782579 | 0.82 | TRPM8 (0.62) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL9951715 | 0.82 | EPHX1 (0.53) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL25782581 | 0.82 | TRPM8 (0.62) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL3274993 | 0.82 | EPHX1 (0.53) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL25782603 | 0.82 | TRPM8 (0.62) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL1863233 | 0.78 | — | — | |
| SCHEMBL9623281 | 0.78 | EPHX1 (0.41) | EPHX1TRPM8TRPA1KCNA5TRPV1 | |
| SCHEMBL11250069 | 0.77 | EPHX1 (0.33) | EPHX1TRPM8TRPA1ALDH1A1 | |
| SCHEMBL19155102 | 0.75 | EPHX1 (0.40) | EPHX1TRPM8TRPA1TRPV1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230202996-A1 | SYNTHETIC METHODS FOR MAKING CARBOXYLIC ACIDS, ESTERS AND LACTONES | P2 SCIENCE, INC. | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230202996-A1 | SYNTHETIC METHODS FOR MAKING CARBOXYLIC ACIDS, ESTERS AND LACTONES | FDFT1, DLST, PCMT1 | EPHX1 1836/4885TRPM8 1032/4885TRPA1 677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.